Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ellis

Showing results (211-220 of 252) with videos related to

Pageof 26
Sort By:
Circulation. Cardiovascular Interventions|April 13, 2012
Impact of drug-eluting stents on distal vesselsKohei Wakabayashi, Gary S Mintz, Neil J Weissman, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisStephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, et al.
Journal of the American College of Cardiology|April 20, 2005
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trialNeil J Weissman, Joerg Koglin, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2004
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularizationStephen G Ellis, Christopher T Bajzer, Deepak L Bhatt, et al.
BMC Medical Genomics|March 30, 2011
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patientsMichael R Elashoff, James A Wingrove, Philip Beineke, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
Lancet (London, England)|September 30, 2018
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trialGregg W Stone, Stephen G Ellis, Tommaso Gori, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Pageof 26

Showing results (211-220 of 252) with videos related to

Sort By:
Pageof 26
Circulation. Cardiovascular Interventions|April 13, 2012
Impact of drug-eluting stents on distal vesselsKohei Wakabayashi, Gary S Mintz, Neil J Weissman, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisStephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, et al.
Journal of the American College of Cardiology|April 20, 2005
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trialNeil J Weissman, Joerg Koglin, David A Cox, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2004
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularizationStephen G Ellis, Christopher T Bajzer, Deepak L Bhatt, et al.
BMC Medical Genomics|March 30, 2011
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patientsMichael R Elashoff, James A Wingrove, Philip Beineke, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
Lancet (London, England)|September 30, 2018
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trialGregg W Stone, Stephen G Ellis, Tommaso Gori, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Pageof 26